Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 18.2% | 15.7% | 9.5% | 55.5% | 16.4% | (17.9%) | 3.9% | 1.8% | 1.9% | 0.5% | 12.1% | 1.1% | 3.0% | (1.0%) | 6.1% | 13.7% | 7.3% | 17.9% | 23.6% | 1.9% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 17.5%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Merck & Co., Inc. have been 14.3% over the past three years, and 15.6% over the past five years.
As of today, Merck & Co., Inc.'s Return on Invested Capital (ROIC) is 17.5%, which is higher than industry median of 13.6%. It indicates that Merck & Co., Inc.'s Return on Invested Capital (ROIC) is Good.